These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27320895)

  • 1. [Red blood cell distribution width combined with lipoprotein-associated phospholipase A2 detection for improving diagnostic accuracy of coronary artery stenosis in patients with coronary artery disease].
    Liu JC; Guo K; Lu H; Li MH; Lai WY; Guo ZG
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):875-9. PubMed ID: 27320895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Correlation of red blood cell distribution width with the severity of coronary artery disease-A single center study".
    Nagula P; Karumuri S; Otikunta AN; Yerrabandi SRV
    Indian Heart J; 2017; 69(6):757-761. PubMed ID: 29174254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
    Cai A; Li G; Chen J; Li X; Li L; Zhou Y
    BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
    Zhang H; Gao Y; Wu D; Zhang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of 25-hydroxyvitamin D, lipoprotein-associated phospholipase A2 and asymptomatic coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang Q; Zhang QQ; He JJ; Dong SQ; Lu Y
    Diabetes Res Clin Pract; 2024 Jun; 212():111681. PubMed ID: 38677367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
    May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
    Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up.
    Brilakis ES; McConnell JP; Lennon RJ; Elesber AA; Meyer JG; Berger PB
    Eur Heart J; 2005 Jan; 26(2):137-44. PubMed ID: 15618069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease.
    Li J; Zhou Z; Niu X; Li H
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome.
    Ma CY; Xu ZY; Wang SP; Peng HY; Liu F; Liu JH; Ren FX
    Chin Med J (Engl); 2018 Jun; 131(12):1444-1449. PubMed ID: 29893361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red cell distribution width is correlated with extensive coronary artery disease in patients with diabetes mellitus.
    Celik A; Karayakali M; Altunkas F; Karaman K; Arisoy A; Ceyhan K; Kadi H; Koc F
    Cardiovasc J Afr; 2017 Sep/Oct 23; 28(5):319-323. PubMed ID: 28906531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
    Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients.
    Ling Y; Tang S; Cao Y; Fu C
    Dis Markers; 2020; 2020():8818358. PubMed ID: 33029257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
    Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
    BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease.
    Ikonomidis I; Kadoglou NN; Tritakis V; Paraskevaidis I; Dimas K; Trivilou P; Papadakis I; Tzortzis S; Triantafyllidi H; Parissis J; Anastasiou-Nana M; Lekakis J
    Atherosclerosis; 2014 May; 234(1):34-41. PubMed ID: 24594367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparision of inflammatory biomarkers for detection of coronary stenosis in patients with stable coronary artery disease.
    Uydu HA; Bostan M; Yilmaz A; Demir A; Atak M; Satiroglu Ö; Temiz A; Cicek Y; Erdogan T; Cetin M; Canga A
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(1):112-8. PubMed ID: 23329531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.
    Mourouzis K; Siasos G; Oikonomou E; Zaromitidou M; Tsigkou V; Antonopoulos A; Bletsa E; Stampouloglou P; Vlasis K; Vavuranakis M; Tousoulis D
    Lipids Health Dis; 2021 Feb; 20(1):12. PubMed ID: 33583415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of intima-media thickness of carotid artery and lipoprotein-associated phospholipase A2 in coronary heart diseases of different types.
    Li Y
    Technol Health Care; 2015; 23 Suppl 1():S147-50. PubMed ID: 26410317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.